All-trans retinoic acid (ATRA) inhibited Notch-1 expression in glioblastoma, breast and ovarian cancer cells, and NICD-1 in glioblastoma cells [54,56,75]. The gene discussed is NOTCH1; the disease is ovarian cancer.